Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The Cannabis ETF (THCX)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
2.9700+0.0800 (+2.77%)
At close: 04:00PM EDT
3.1000 +0.13 (+4.38%)
After hours: 06:51PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Previous Close2.8900
Open2.8600
Bid2.4500 x 800
Ask3.1000 x 800
Day's Range2.8600 - 3.0399
52 Week Range2.8000 - 13.2500
Volume62,852
Avg. Volume44,663
Net Assets31.87M
NAV3.87
PE Ratio (TTM)N/A
Yield1.18%
YTD Daily Total Return-55.22%
Beta (5Y Monthly)0.00
Expense Ratio (net)0.75%
Inception Date2019-07-09
  • MarketWatch

    Canada's Hexo to sell Tyson 2.0 cannabis

    Hexo Corp. said Tuesday it inked a deal to be the exclusive Canadian producer of Tyson 2.0 cannabis products including premium and affordable cannabis flower, concentrates and consumables. Tyson 2.0 co-founder Mike Tyson said, "Canadians have been eager to try the Tyson 2.0 line." Financial terms of the deal were not disclosed. Tyson told MarketWatch earlier this month that Tyson 2.0 remains a bigger focus for him than other business ventures. Shares of Hexo are down 70.3% in 2022, compared to a

  • MarketWatch

    Canada study shows increase in cannabis poisoning in kids up to nine years old after legalization

    Hospitalizations for cannabis poisoning of children zero to nine years old in Canada increased after adult use cannabis sales began in late 2018 and again after 2020 when edible cannabis products became legal in every province except Quebec, according to a study published Wednesday by the New England Journal of Medicine. During the roughly seven-year study period from early 2015 to late 2021, 581 hospitalizations took place for for cannabis poisoning in children, at a mean age of 3.6 years, the

  • MarketWatch

    Organigram Q3 revenue tops estimates, guides for higher revenue in Q4

    Organigram Holdings Inc. posted a net loss of C$2.8 million ($2.1 million) for its fiscal third quarter to May 31, narrower than the loss of C$4.0 million posted in the year-earlier period. The Canadian cannabis company did not offer a per-share number. Revenue net of excise taxes rose to C$38.1 million from C$20.3 million a year ago, ahead of the FactSet consensus of C$33.7 million. The company said the revenue number was a company record and that it expects to surpass it in the fourth quarter.

Advertisement
Advertisement